Literature DB >> 21558626

Technologies and strategies for people with communication problems following brain injury or stroke.

Tracey Wallace1, Adina Bradshaw.   

Abstract

Communication problems experienced following a brain injury or stroke not only impact a person's ability to participate in their desired social and vocational roles but may also impact their ability to participate in decision-making about their care, participate in therapy and receive counseling and education. Many technologies exist, including Augmentative and Alternative Communication (AAC), which can help increase communication and life participation following a brain injury or stroke. This article will define and describe a variety of AAC technologies and interventions for people with communication problems following acquired brain injury as well as discuss assessment, training and funding issues.

Entities:  

Mesh:

Year:  2011        PMID: 21558626     DOI: 10.3233/NRE-2011-0649

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  3 in total

Review 1.  Systematic review of supportive care needs in patients with primary malignant brain tumors.

Authors:  Elizabeth Ford; Susan Catt; Anthony Chalmers; Lesley Fallowfield
Journal:  Neuro Oncol       Date:  2012-02-03       Impact factor: 12.300

2.  Technology-aided programs for post-coma patients emerged from or in a minimally conscious state.

Authors:  Giulio E Lancioni; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Marta Olivetti Belardinelli; Francesca Buonocunto; Fiora D'Amico; Jorge Navarro; Crocifissa Lanzilotti; Gabriele Ferlisi; Floriana Denitto
Journal:  Front Hum Neurosci       Date:  2014-12-05       Impact factor: 3.169

Review 3.  Technology-based intervention programs to promote stimulation control and communication in post-coma persons with different levels of disability.

Authors:  Giulio E Lancioni; Andrea Bosco; Marta Olivetti Belardinelli; Nirbhay N Singh; Mark F O'Reilly; Jeff Sigafoos; Doretta Oliva
Journal:  Front Hum Neurosci       Date:  2014-02-11       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.